DIT Acquires Lifeline PICC

Peter Harris, President & Chief Executive Officer of DIT, commented that "bringing Lifeline PICC and Kathy into our growing family will contribute to our continued success. 

Dynamic Infusion Therapy, LLC (“DIT”), a longstanding provider of outsourced vascular access services, is excited to announce the acquisition of Lifeline PICC in Tulsa, OK. Under the leadership of Kathy Wagner, RN, CRNI, VA-BC, the founder and owner of the company, Lifeline PICC has been providing high quality services and supplies for peripherally inserted central catheters (PICCs) at healthcare organizations across the Tulsa area for the past 8 years.

According to Wagner, “DIT was a natural choice to support the continued growth of my business.  I have full confidence in their ability to carry on the legacy of what we’ve been building over the years.”  Wagner will be joining the leadership team of DIT and will oversee the integration of her company during the next few months.

Peter Harris, President & Chief Executive Officer of DIT, commented that “bringing Lifeline PICC and Kathy into our growing family will contribute to our continued success.  Our nurses already insert vascular access devices on-demand for about 100,000 patients a year.  Adding the Tulsa market will expand our geographic footprint further allowing us to make a difference to the patients and healthcare organizations there.”

In connection with the transaction, DIT welcomed the experienced Lifeline PICC nurses to its team and will be providing services to several prominent healthcare clients in the Tulsa area. Both companies share a clinical model that focuses on lowering customer costs while providing better patient outcomes.

More patients receive PICCs from DIT than any other outsourced provider in the U.S., and DIT’s nurses have consistently achieved an overall success rate greater than 99%. The Joint Commission first accredited DIT a decade ago and has awarded DIT its Gold Seal of Approval.  In early 2021, RiverGlade Capital, a healthcare-focused private equity firm, partnered with DIT to build on its reputation for clinical excellence.

More

Artificial Intelligence Tools Make Education Materials More Patient Friendly

“Our study shows that widely used large language models have the potential to transform patient education materials into more readable content, which is essential for patient empowerment and better health outcomes,” said Study senior author Jonah Feldman, MD, medical director of transformation and informatics at NYU Langone.

CorWave Completes 6-Month In Vivo Study for Clinical Trials Initiation

In vivo studies demonstrated the pump’s successful operation for a period of up to six months. Additionally, nine chronic ovine implants were conducted for 60 days with no device failure or sign of thrombosis at explant. These significant milestones mark the final stage of CorWave’s preclinical development, paving the way for its First-In-Human study.